Rare Disease Archives - DelveInsight

Rare Disease

Another Failed NASH Drug; Takeda’s Dengue Shot; Innovent’s Cholangiocarcinoma Clinical Trial; TLX66 in AL Amyloidosis
TLX66 in AL Amyloidosis; Takeda’s Dengue Shot; Innovent’s Cholangiocarcinoma Clinical Trial; Anot...

TLX66 Meets Study Objectives, Holding Out in AL AmyloidosisTelix Pharmaceuticals reported the results from the TRALA trial (Targeted Radiotherapy for AL Amyloidosis), a Phase I/IIa trial evalu...


Rare Cancer Market | Soft Tissue Sarcoma Market | Multiple Myeloma Market | Glioblastoma Multiforme Market | Cholangiocarcinoma Market | Synovial Sarcoma Market
Rare Cancer Market: A Global Crusade on what is a ‘less common cancer’?

Cancer is often challenging, however, diagnosis of rare cancer poses extra difficulties. Of all the diagnosed cancers, approximately 22% of the cases are rare cancers. According to the US National...


Rare Disease Market Drivers | Orphan Drugs
What are the Market Drivers Fueling the Rare Disease Market?

Rare diseases–also go by the name Orphan diseases–are the conditions that do not affect many individuals out there in one particular geographic area. Going deeper into the definition, it also mean...


Erythropoietic Protoporphyria Market Outlook
Emerging Research Continues To Transform Erythropoietic Protoporphyria Market Outlook

Lack of knowledge about conditions, situations, or body ailments that are unexplainable often scares people and leads to people jumping to conclusions or say myths that are not at all backed by sc...


Hypofibrinogenemia Market | Rare Bleeding Disorders
Hypofibrinogenemia Market: Limited Pipeline Therapies, Abundant Opportunities

Like troops at the forefront of any battle, our immune system continually marches to protect us from foreign elements and invaders, including bacteria, viruses, and others. Whenever with a swift w...


Rare diseases challenges | Rare diseases clinical trials, incidence, and funding
The Paradox of Rare: Chalking out Challenges in the Rare Disease Market

How is a Rare disease defined? Well, it depends on the geography in question, since there is no universal definition, even so, the definition revolves around the point of prevalence or incidence o...


Keratoconus Market
Keratoconus – Rare? Not really!

The Keratoconus market will be dominated by lenses, cross-linking procedures as well as IVMED-80, if approved in the coming decade.Keratoconus, away from the general perception of a rare disea...


Fragile X Syndrome Market
Fragile X Syndrome Market

AI-driven treatment approach and growing Fragile X Syndrome market sizeHealx Pharma has recently partnered with Boehringer Ingelheim to advance the treatment market and invest in R&D rel...


Pharma News
Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

A leading global international investment firm, Omega Funds has announced the closure of its sixth fundraising USD 438 Million.More than decade old Life Sciences-based investment firm special...


Gaucher disease Market
Gaucher disease Market Analysis: Rich Pipeline Drives the Market Ahead

Gaucher Disease Market is anticipated to enhance in the forecast period owing to a strong Gaucher disease pipeline.According to the National Organization of Rare Diseases, Gaucher disease is a...


Editor's Pick
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia G...

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...

Scrutinizing the West Syndrome Market Space from Growth Perspectives

West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...

Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the...

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.